Efficacy and Safety of Fingolimod in Daily Practice: Experience of an Academic MS French Center

Efficacy and Safety of Fingolimod in Daily Practice: Experience of an Academic MS French Center

IntroductionFingolimod (Fg), a sphingosine 1-phosphate receptor modulator, decreases the annual relapse rate (ARR) in relapsing-remitting multiple sclerosis (RRMS). The aim of this study was to assess the efficacy and safety of Fg in daily practice in patients with RRMS, previously treated with nata...

Full description

Bibliographic Details
Main Authors: Thomas Roux, Elisabeth Maillart, Jean-Sébastien Vidal, Sophie Tezenas du Montcel, Catherine Lubetzki, Caroline Papeix
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-05-01
Series:Frontiers in Neurology
Subjects:
fingolimod
relapsing-remitting multiple sclerosis
efficacy
annual relapse rate
disability
safety
Online Access:http://journal.frontiersin.org/article/10.3389/fneur.2017.00183/full

Internet

http://journal.frontiersin.org/article/10.3389/fneur.2017.00183/full

Similar Items